» Articles » PMID: 30256483

Histopathological Changes in Androgenized Ovaries Are Recovered by Melatonin Treatment

Overview
Publisher Wiley
Specialty Pathology
Date 2018 Sep 27
PMID 30256483
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Nandrolone decanoate (ND) is a synthetic steroid, which promotes adverse effects on the ovarian tissue, and melatonin (MLT) exhibits a number of beneficial properties in the reproductive system. This study evaluated the general features of the ovarian tissue and the immunoexpression of sex steroid receptors in ND-treated rats that were submitted to short-term melatonin treatment. Adult rats received mineral oil (control group) and ND at doses of 7.5 mg/kg for 15 days (ND-treated group). The treatment with MLT (10mg/kg for 7 days) was given alone, before or in combination with ND. All ND-treated animals showed persistent dioestrus. In the androgenized groups that received MLT, ovarian morphology and size, and the number/area of corpora lutea were recovered. The number of healthy and atretic follicles was recovered when MLT was administered prior to ND; this was similar to the ovaries of control and MLT groups. There was a decrease in estrogen receptors immunostaining in the follicles of androgenized rats that were treated with MLT, and pretreatment with MLT reduced the expression of androgen receptor in atretic follicles and corpora lutea, when compared with ND-treated group. We conclude that MLT treatment recovered the histopathological aspects of the androgenized ovaries, and MLT pretreatment was the most effective.

Citing Articles

Comparative ovarian morphophysiology of rats and Zebrafish after exposure to nandrolone decanoate.

Cavalcante J, Martins S, Martins J, Lobato J, Sales Y, Bittencourt S Anim Reprod. 2025; 22(1):e20240046.

PMID: 39867302 PMC: 11758781. DOI: 10.1590/1984-3143-AR2024-0046.


Histopathological changes in androgenized ovaries are recovered by melatonin treatment.

de Souza B, de Almeida Chuffa L, Simao V, Camargo I Int J Exp Pathol. 2018; 99(4):158-171.

PMID: 30256483 PMC: 6157297. DOI: 10.1111/iep.12283.

References
1.
Drummond A, Fuller P . Ovarian actions of estrogen receptor-β: an update. Semin Reprod Med. 2012; 30(1):32-8. DOI: 10.1055/s-0031-1299595. View

2.
Bondi C, Alonso-Gonzalez C, Clafshenkel W, Kotlarczyk M, Dodda B, Sanchez-Barcelo E . The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice. Eur J Obstet Gynecol Reprod Biol. 2013; 174:80-5. DOI: 10.1016/j.ejogrb.2013.11.027. View

3.
Bordbar H, Mesbah F, Talaei T, Dehghani F, Mirkhani H . Modulatory effect of gonadotropins on rats' ovaries after nandrolone decanoate administration: a stereological study. Iran J Med Sci. 2014; 39(1):44-50. PMC: 3895894. View

4.
Takasaki A, Nakamura Y, Tamura H, Shimamura K, Morioka H . Melatonin as a new drug for improving oocyte quality. Reprod Med Biol. 2018; 2(4):139-144. PMC: 5904612. DOI: 10.1111/j.1447-0578.2003.00035.x. View

5.
Belardin L, Simao V, Leite G, de Almeida Chuffa L, Camargo I . Dose-dependent effects and reversibility of the injuries caused by nandrolone decanoate in uterine tissue and fertility of rats. Birth Defects Res B Dev Reprod Toxicol. 2014; 101(2):168-77. DOI: 10.1002/bdrb.21104. View